Rapamycin has a unique stature of being a miracle drug with numerous applications including many are yet to be verified. When it was isolated for the first time in 1972, researchers did not think the possibility of the drugs in vat areas and used just as an anti-fungal compound. The researches in the later years proved that it could cure many health conditions of the human body. Among the researchers, Mikhail Blagosklonny has dedicated his time and efforts in Rapamycin significantly and identified many applications of the drug in the modern medical science. For people who do not know the extensive range of applications of the drug, Blagosklonny explained some of the best uses of it in the medical world. Read more about Mikhail on Crunchbase.
He says that the drug exhibits excellent immunosuppressant properties which makes it an ideal choice for suppressing the body rejection tendency when transplanting new organs into it. While other drugs with similar characteristics bear a higher level of toxicity in kidneys, Rapamycin showcases the least. It is also the best option for treating the hemolytic-uremic condition which is a mix of kidney failure, meager platelet count, and anemia. When going for a kidney transplant, the new organ found to be prone to the disease and, Rapamycin has the power to limit such probabilities.
The researchers of Blagosklonny showed that the drug could even be useful in treating cancer condition due to its antiproliferative properties. The drug found to be increasing the immunity of the human body especially against cancer cells – playing a major role in restricting the disease as well as improving recovery. When taken in right doses, Rapamycin creates a regression against cancer cells in the human body. It is also the primary choice of drug in TSC and facial angiofibromas as well. The most important application of Rapamycin is it improves the quality lifespan of humans if taken in right doses. Mikhail Blagosklonny did extensive research in the area, and the tests on mice produced excellent results as well. He has also set his plans to make his tests and trials extended to other organisms to arrive more accurate conclusions. Read more on Impact Journals.
Blagosklonny is also credited with philanthropic and academic contributions as well. He has expressed his vision that every individual across the world gets the best treatment options without considering the financial status. While he conducts researches in aging and cancer, the focus of Blagosklonny is to produce results based on effectiveness and affordability. He has done vast research on the relationship between cancer and the age – people who are above a certain age found to be more vulnerable to the disease.
While coming to cancer research and treatment development, Blagosklonny wanted solutions that can specifically target the diseased cells without making any trouble to the healthy cells. It is already proved that such a precision medication option is vital in the overall recovery of the patient. While conducting researches, Blagosklonny does not think that he would make a breakthrough in cancer or anti-aging. Instead, he wants to ensure that he is encouraging his colleagues and junior researchers to continue from where he stops.
Read more: http://www.aging-us.com/article/100591/text